LeMaitre Vascular Inc. (LMAT) exhibits 71.5% gross margins and 14.7% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 28.3x enterprise multiple and 4.8% implied options volatility.
Sustained 71.5% gross profitability converts into 27.2% operating margin and 14.7% ROIC, outpacing sector cost of capital.
ROIC: 14.7% // GM: 71.5%YoY revenue trajectory of +13.5% paired with 4.17% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +13.5% // FCF YLD: 4.17%Altman Z-Score of 7.30 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 7.30 // F-SCORE: 8/9Trading at 33.8x trailing P/E (28.4x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 33.8x // EV/EBITDA: 28.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $85.27 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 23.1% net margins.
NET MARGIN: 23.1% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for LMAT & activate live FRED threshold breach alerts.